Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nitroglycerin sublingual - Pohl-Boskamp

Next Previous
Drug Profile

Nitroglycerin sublingual - Pohl-Boskamp

Alternative Names: GoNitro; Nitrolingual Pumpspray

Latest Information Update: 30 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pohl-Boskamp
  • Class Antineoplastics; Erectile dysfunction therapies; Heart failure therapies; Ischaemic heart disorder therapies; Nitro compounds; Organic nitrates; Small molecules; Sugar alcohols; Vasodilators
  • Mechanism of Action Guanylate cyclase stimulants; Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Angina pectoris
  • Phase II Peripheral arterial occlusive disorders

Most Recent Events

  • 14 Jan 2019 Pohl-Boskamp completes a phase II trial in Peripheral arterial occlusive disorders (In adults, In the elderly) in Germany before January 2019 (EudraCT2016-004460-19)
  • 20 Nov 2017 Navamedic enters into a preliminary long-term distribution agreement with Pohl-Boskamp for the Nordic launch and commercialisation of Nitroglycerin sublingual
  • 20 Apr 2017 Phase-II clinical trials in Peripheral arterial occlusive disorders (In adults, In the elderly) in Germany (Sublingual) (EudraCT2016-004460-19)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top